Rate in Product Approvals Influencing Malignant Glioblastoma Market to Produce an Acoustic CAGR of 7.40% During Forecast 2019-2025

20/gen/2021 06:02:49 Market Research Future Contatta l'autore

Questo comunicato è stato pubblicato più di 30 giorni fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Market Highlights:
The global Glioblastoma Market is expected to register a CAGR of 7.40% during the forecast period with a market value of USD 1,643.4 million till 2025. Glioblastoma is a malignant grade IV tumor. The increasing incidence rates, the rise in product approvals, and growing research in the field are projected to drive the growth of the global glioblastoma market. On the other hand, the termination of many clinical trial drug candidates is anticipated to hamper the growth of the market.
also read @ https://www.icrowdde.com/2021/01/05/glioblastom-marktgrose-wird-voraussichtlich-16434-mio-usd-bei-einem-cagr-von-74-bis-2025-erreichen-marktforschungszukunft/

Key Players:
• F. Hoffmann-La Roche Ltd
• Amgen Inc
• Arbor Pharmaceuticals
• Sun Pharmaceutical Industries Ltd
• Merck & Co
• Teva Pharmaceutical Industries Ltd
Regional Analysis:
The global glioblastoma market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The Americas is likely to hold the largest share of the global glioblastoma market during the assessment period. The increasing incidence rate of glioblastoma and high funding for research & development projects in the US and Canada are likely to support the dominance of the Americas during the forecast period. The approval of drugs in these countries help in maximizing the growth of the market in this region as well.
The Europe market established substantial growth in the market due to the increasing number of clinical trials in this region.
Asia-Pacific is estimated to be the fastest-growing region in the global market due to the huge patient population, improving healthcare infrastructure, and growing per capita disposable incomes.
The glioblastoma market in the Middle East & Africa is expected to witness gradual growth due to the increasing availability of new treatment methods.
Read More @ https://www.marketresearchfuture.com/reports/glioblastoma-market-8307

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl